Clinical trial
Development and Validation of Risk Prediction Model for Severe Ventricular Arrhythmias in Patients With Mitral Valve Prolapse
NCT07830888 is registered in ClinicalTrials.gov with Oslo University Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Development and Validation of Risk Prediction Model for Severe Ventricular Arrhythmias in Patients With Mitral Valve Prolapse
- Lead sponsor
- Oslo University Hospital
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- August 7, 2026
- Completion date
- September 30, 2035
- Enrollment
- 500 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
mitral valve prolapse, ventricular arrhythmias and cardiac arrest